[EN] CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE LA CÉRAMIDE GALACTOSYLTRANSFÉRASE POUR LE TRAITEMENT DE MALADIES
申请人:BIOMARIN PHARM INC
公开号:WO2017214505A1
公开(公告)日:2017-12-14
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
Catalyst‐Free Electrosynthesis of Benzimidazolones through Intramolecular Oxidative C−N Coupling
作者:Jiang‐Sheng Li、Pan‐Pan Yang、Xin‐Yun Xie、Si Jiang、Li Tao、Zhi‐Wei Li、Cui‐Hong Lu、Wei‐Dong Liu
DOI:10.1002/adsc.202000198
日期:2020.5.12
The electrochemicalsynthesis of N, N’‐disubstituted benzimidazolones from ureas through an intramolecular anodic dehydrogenative N−H/C−H coupling has been developed. The reaction undergoes under the undivided electrolysis conditions and obviates the need for any catalysts and chemical oxidants.